ID 369376128 © Dzmitry Auramchik | Dreamstime.com
dreamstime_xxl_369376128
July 3, 2025
NeoGenomics, Inc. announced the launch of PanTracer Tissue, a next-generation solid tumor profiling assay, including the option to add testing for homologous recombination deficiency...
Courtesy of the CDC
22882
Streptococcus agalactiae, also known as Group B strep (GBS), is a Gram-positive colonizing bacterium that can cause life-threatening complications for newborns when it is passed...
By StudioLaMagica on Adobe Stock
adobestock_275251819
June 17, 2025
Indiana University School of Medicine professor Jeff Dage, PhD’s research aided the Food and Drug Administration (FDA) clearance of Fujirebio’s Lumipulse G pTau 217...
ID 348802434 © Yuri Arcurs | Dreamstime.com
dreamstime_xxl_348802434
June 16, 2025
The first national proficiency testing program to help laboratories detect and accurately identify the H5N1 strain of bird flu will be delivered this fall, according to the College...
By kamiphotos on Adobe Stock
adobestock_559095551_1
June 13, 2025
Recent Mayo Clinic research supports the reliability of the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio for diagnosing Alzheimer's, according to a release. The test,...
June 13, 2025
Maine Molecular Quality Controls has released the Birlinn CoV2-Flu-RSV Control Panel M509, intended for use as a quality control to monitor the performance of in vitro laboratory...
ID 196480927 © Iryna Drozd | Dreamstime.com
dreamstime_xxl_196480927_1
June 13, 2025
One of the largest real-world studies of a sepsis diagnostic reveals that Cytovale’s IntelliSep, a U.S. Food and Drug Administration (FDA)-cleared rapid host response diagnostic...
Image courtesy of LVIS Corporation
Visual showing NeuroMatch Elite interface by LVIS, featuring a 3D brain model with colored nodes and connecting lines representing brain activity, overlaid on an EEG background. Image courtesy of LVIS Corporation.
June 10, 2025
LVIS Corp announced the upcoming U.S. release of NeuroMatch Elite.NeuroMatch Elite launches with two capabilities - Seizure Source Localization and Spike Source Localization. ...
By angellodeco on Adobe Stock
adobestock_114090939
June 10, 2025
Diasorin announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the LIAISON PLEX Gram-Positive Blood Culture Assay, the final syndromic...
ID 80084022 © Per Boge | Dreamstime.com
dreamstime_xxl_80084022
June 9, 2025
QIAGEN announced the expansion of its oncology diagnostics portfolio with two strategic partnerships to advance the use of minimal residual disease (MRD) testing in clinical trials...
ID 159921496 © Oksana Ryzhinskaya | Dreamstime.com
dreamstime_xxl_159921496
June 6, 2025
Foresight Diagnostics announced a strategic, worldwide partnership with QIAGEN to develop and commercialize a kit-based version of Foresight’s CLARITY assay, with the goal...